A simple point-of-care assay accurately detects anti-spike antibodies after SARS-CoV-2 vaccination

OBJECTIVE: Lateral flow assays (LFA) are sensitive for detecting antibodies to SARS-CoV-2 proteins within weeks after infection. This study tested samples from immunocompetent adults, and those receiving treatments for chronic inflammatory diseases (CID), before and after mRNA SARS-CoV-2 vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Greene, Sarah E., Huang, Yuefang, Kim, Wooseob, Liebeskind, Mariel J., Chandrasekaran, Vinay, Liu, Zhuoming, Deepak, Parakkal, Paley, Michael A., Lew, Daphne, Yang, Monica, Matloubian, Mehrdad, Gensler, Lianne S., Nakamura, Mary C., O'Hallaran, Jane A., Presti, Rachel M., Whelan, Sean P.J., Buchser, William J., Kim, Alfred H.J., Weil, Gary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831968/
https://www.ncbi.nlm.nih.gov/pubmed/36644774
http://dx.doi.org/10.1016/j.jcvp.2023.100135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831968/
https://www.ncbi.nlm.nih.gov/pubmed/36644774
http://dx.doi.org/10.1016/j.jcvp.2023.100135

Ejemplares similares